Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (171-180 of 904) with videos related to

Pageof 91
Sort By:
Neurology|April 17, 2015
Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndromeChafic Karam, Christopher J Klein, Angela Dispenzieri, et al.
Mayo Clinic Proceedings|February 6, 2019
Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart FailureIan C Chang, Angela Dispenzieri, Christopher G Scott, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 23, 2005
Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosisNelson Leung, Angela Dispenzieri, Fernando C Fervenza, et al.
American Journal of Hematology|April 23, 2013
Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometryAnita D'Souza, Jason Theis, Patrick Quint, et al.
JACC. Case Reports|March 21, 2025
Artificial Intelligence-Enhanced Electrocardiogram: A Possible Mechanism to Monitor Cardiac Amyloidosis Therapeutic ResponseReid P Schlesinger, Iuri Ferreira Felix, David M Harmon, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemiaRobert A Kyle, Joanne Benson, Dirk Larson, et al.
Annals of Hematology|January 12, 2007
Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantationJeroen S Goede, Benjamin Misselwitz, Christian Taverna, et al.
Blood|December 15, 2018
Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assayEli Muchtar, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 8, 2005
Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantationNelson Leung, Jeff M Slezak, Erik J Bergstralh, et al.
Blood|July 19, 2011
Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myelomaRishi K Wadhera, Robert A Kyle, Dirk R Larson, et al.
Pageof 91

Showing results (171-180 of 904) with videos related to

Sort By:
Pageof 91
Neurology|April 17, 2015
Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndromeChafic Karam, Christopher J Klein, Angela Dispenzieri, et al.
Mayo Clinic Proceedings|February 6, 2019
Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart FailureIan C Chang, Angela Dispenzieri, Christopher G Scott, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 23, 2005
Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosisNelson Leung, Angela Dispenzieri, Fernando C Fervenza, et al.
American Journal of Hematology|April 23, 2013
Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometryAnita D'Souza, Jason Theis, Patrick Quint, et al.
JACC. Case Reports|March 21, 2025
Artificial Intelligence-Enhanced Electrocardiogram: A Possible Mechanism to Monitor Cardiac Amyloidosis Therapeutic ResponseReid P Schlesinger, Iuri Ferreira Felix, David M Harmon, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemiaRobert A Kyle, Joanne Benson, Dirk Larson, et al.
Annals of Hematology|January 12, 2007
Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantationJeroen S Goede, Benjamin Misselwitz, Christian Taverna, et al.
Blood|December 15, 2018
Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assayEli Muchtar, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 8, 2005
Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantationNelson Leung, Jeff M Slezak, Erik J Bergstralh, et al.
Blood|July 19, 2011
Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myelomaRishi K Wadhera, Robert A Kyle, Dirk R Larson, et al.
Pageof 91